SELECTAR - Selection for antimicrobial resistance by antimicrobial production waste
SELECTAR - Selection for antimicrobial resistance by antimicrobial production waste
批准号:
NE/T01301X/1
负责人:
Alan McNally
金额:
$127.01万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2020
资助国家:
英国
项目状态:
未结题
起止时间:
2020 至 --
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Antibiotics are one of the most crucial medicines on the planet. Without them we are unable to treat the vast majority of infectious diseases, ranging from life threatening intestinal infections and blood stream infections, to treating debilitating chronic infections such as urinary tract infections and respiratory infections. Antibiotics are required to prevent the deaths of patients suffering from respiratory diseases such as CF and COPD, and are the corner stone of treatments for diseases such as cancer and leukaemia where it is necessary to prevent infections during treatment. The majority of the worlds antibiotics are produced in pharmaceutical factories in India. Antibiotics can be produced by chemical synthesis or by growing vast number of the microorganisms which naturally produce them. Either method results in the production of large quantities of waste, potentially containing active antibiotics and/or chemicals which may be toxic to bacteria and other cell types. This waste goes through treatment plants before being released into the environment. This creates an enormous potential issue, as the more we expose bacteria to antibiotics the faster they evolve resistance to the drugs meaning they cant be used to treat infections. There is also the possibility that release of waste into the environment kills all bacteria except those resistant, decimating important bacterial ecosystems and increasing resistant bacteria.We desperately need to know exactly how much the release of antibiotic production waste leads to the feared end results mentioned above . To do this we will sample environments into which antibiotic production waste is released, and compare them to pristine environments. This will allow us to determine exactly what effect the waste has on the microbial ecosystem, does it kill all beneficial bacteria to only leave harmful resistant bacteria alive. We will carefully examine the waste to determine exactly how much active antibiotic is released but also which other potentially toxic chemicals are contained within the waste that may affect bacteria. And we will then test the ability of these chemicals to also induce resistant bacteria, as a consequence of them trying to avoid chemical killing.
期刊论文(4)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1128/msystems.01193-23
发表时间:
2024-02-20
期刊:
MSYSTEMS
影响因子:
6.4
作者:
[Hall,Rebecca J., Snaith,Ann E., McNally,Alan]
通讯作者:
McNally,Alan
Understanding the pathway to multidrug resistant bacterial pathogens
-
批准号:BB/W020602/1
-
项目类别:Research Grant
-
资助金额:$111.36万
-
财政年份:2023
-
负责人:Alan McNally
-
依托单位:
DETECTIVE: Dissemination and resistance mechanisms of carbapenem-resistant Gram-negative bacilli
-
批准号:MR/S013660/1
-
项目类别:Research Grant
-
资助金额:$173.35万
-
财政年份:2019
-
负责人:Alan McNally
-
依托单位:
The evolutionary emergence of multidrug resistant bacterial pathogens
-
批准号:BB/R006261/1
-
项目类别:Research Grant
-
资助金额:$52.16万
-
财政年份:2018
-
负责人:Alan McNally
-
依托单位:
PRADA (Portable Rapid Automated DNA Analysis)
-
批准号:TS/G001898/1
-
项目类别:Research Grant
-
资助金额:$23.55万
-
财政年份:2008
-
负责人:Alan McNally
-
依托单位:
国内基金
海外基金
Intelligent Patent Analysis for Optimized Technology Stack Selection:Blockchain BusinessRegistry Case Demonstration
-
批准号:--
-
项目类别:外国学者研究基金项目
-
资助金额:--
-
批准年份:2024
-
负责人:USHARANI HAREESH GOVINDARA JAN
-
依托单位:
连锁群选育法(Linkage Group Selection)在柔嫩艾美耳球虫表型相关基因研究中应用
-
批准号:30700601
-
项目类别:青年科学基金项目
-
资助金额:17.0万元
-
批准年份:2007
-
负责人:董辉
-
依托单位: